KNOWLEDGE AND AWARENESS ON PRESCRIPTION DRUG ADVERTISEMENT AMONG DENTAL STUDENTS IN CHENNAI Original Research
Article Sidebar
Main Article Content
Abstract
Aim and objectives: The aim of this research is to find out current knowledge and awareness on prescription drug advertisement among dental students especially in Chennai, Tamil Nadu. This helps in gaining knowledge on dental student's awareness in drug advertising based on their previous and current knowledge in medical field.
Materials and Methods: Questionnaire consisting of 15 questions are given through online communication system (Whatsapp Apps) with attached link to the online questionnaire that had been prepared earlier (http://app.surveyplanet.com). 120 students from 4 dental institutions in Chennai took part in this survey.
Results: Awareness of dental students in Chennai is calculated based on their best answer response toward the prescription drug advertising based on their current knowledge. Collecting all responses, most of them heard or have seen prescription drug advertisement from television (31.67%) and internet (29.17%). Other students have heard about it on television or seen it through newspaper (16.67%), magazines (29.17%), and 10.00% students have not heard or seen any advertisement about it. Majority of students (58.33%) do not know what content are not required to be advertised, and 41.67% knew about it. Most of the respondents (35.00%) are not sure about the drug advertising regulations in their country, 34.17% are not aware and only 30.83% claimed that they are aware about the regulations. All of the respondents (100%) recommend the patients for specialist consultation before taking any drugs.
Conclusion: The prescription drug advertisement is very important in dental health care because it will determine the success of any treatment done. The misuse of prescription drugs may lead to negative consequences that may affect the treatment. The higher percentage of awareness might be due to the knowledge the students acquire of dental syllabus before entering the clinical years.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
Ventola, C.L., Direct-to-consumer pharmaceutical advertising: therapeutic or toxic? Pharmacy and Therapeutics, 2011. 36(10): p. 669.
Abel, G.A., et al., Direct-to-consumer advertising in oncology. The Oncologist, 2006. 11(2): p. 217-226.
Donohue, J.M., M. Cevasco, and M.B. Rosenthal, A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med, 2007. 2007(357): p. 673-681.
Almasi, E.A., et al., What are the public health effects of direct-to-consumer drug advertising? PLoS Med, 2006. 3(3): p. e145.
Shuchman, M., Drug risks and free speech—Can Congress ban consumer drug ads? New England Journal of Medicine, 2007. 356(22): p. 2236-2239.
Kuehn, B.M., FDA weighs limits for online ads. JAMA, 2010. 303(4): p. 311-313.
Connors, A.L., Big bad pharma: an ethical analysis of physician-directed and consumer-directed marketing tactics. Alb. L. Rev., 2009. 73: p. 243.
Silversides, A., Abramson: direct-to-consumer advertising will erode health care. Canadian Medical Association Journal, 2008. 178(9): p. 1126-1127.
Morgan, S.G., Direct-to-consumer advertising and expenditure on prescription drugs: a comparison of experiences in the United States and Canada. Open Medicine, 2007. 1(1): p. 37-45.
Boden, W.E. and G.A. Diamond, DTCA for PTCA—Crossing the Line in Consumer Health Education? New England Journal of Medicine, 2008. 358(21): p. 2197-2200.
Donohue, J., A history of drug advertising: the evolving roles of consumers and consumer protection. Milbank Quarterly, 2006. 84(4): p. 659-699.
Calfee, J.E., Public policy issues in direct-to-consumer advertising of prescription drugs. Journal of Public Policy & Marketing, 2002. 21(2): p. 174-193.
Jacoby, J. and C. Small, The FDA approach to defining misleading advertising. The Journal of Marketing, 1975: p. 65-68.
Humphreys, G., Direct-to-consumer advertising under fire: pharmaceutical companies that market medicines directly to consumers in the United States of America (USA) are under increasing pressure to rein in their inventive urges, while attempts to establish a bridgehead in Europe look doomed to failure. Bulletin of the World Health Organization, 2009. 87(8): p. 576-578.
Kessler, D.A. and W.L. Pines, The federal regulation of prescription drug advertising and promotion. JAMA, 1990. 264(18): p. 2409-2415.
Greene, J.A. and D. Herzberg, Hidden in plain sight marketing prescription drugs to consumers in the twentieth century. American journal of public health, 2010. 100(5): p. 793-803.
Mintzes, B., S.N. Bonaccorso, and J.L. Sturchio, For and against: Direct to consumer advertising is medicalising normal human experience. British medical journal, 2002. 324(7342): p. 908.
Control, C.f.D. and Prevention, CDC grand rounds: prescription drug overdoses-a US epidemic. MMWR. Morbidity and mortality weekly report, 2012. 61(1): p. 10.
Control, C.f.D. and Prevention, Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008. MMWR. Morbidity and mortality weekly report, 2011. 60(43): p. 1487.
Friedman, R.A., The changing face of teenage drug abuse—the trend toward prescription drugs. New England Journal of Medicine, 2006. 354(14): p. 1448-1450.
Rosendal, M., F. Olesen, and P. Fink, Direct to consumer advertising. Psychosomatics, 2002. 43: p. 93- 131.
Pines, W.L., Direct-to-consumer advertising. The Annals of pharmacotherapy, 2000. 34(11): p. 1341-1344.